
How European BioTech is Changing Cancer Care
Shownotes
Key points:
- Bridging the gap between scientific breakthroughs and real-world cancer care remains one of Europe's biggest challenges
- Sustainable, microalgae-based biomanufacturing could become a serious alternative for producing antibodies and other biologics
- Moving cell therapy from highly personalised treatments to scalable, "off-the-shelf" solutions is key to reaching far more patients
- AI and generative chemistry open up RNA as a drug target that traditional discovery has struggled to reach Europe excels at world-class research, but scaling BioTech companies still faces friction in funding, infrastructure, and ecosystem support
- Practical lessons from founders on turning research into a company - and how Women TechEU creates impact well beyond the grant itself
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.
The Women TechEU scheme is an EU-funded project supporting women leading deep tech startup companies from Europe. As part of the consortium team implementing the programme, our mission is to foster inclusive innovation by supporting women-led startups, including under-represented deep tech sectors and European regions. We believe that diversity drives innovation, and we are here to provide women in deep tech with more opportunities, resources, and support in order to build market-shaping companies at global level.
Between 2026-2028, the current project consortium will run a continuous open call with 4 cut-off dates. Following a rigorous evaluation process, 160 total beneficiaries will be selected. Each beneficiary will receive €75k grants (non-dilutive finance), as well as a tailored package of mentorship, training, expert guidance, matchmaking and networking opportunities, and support in bridging the gap to other EIC funding and support schemes.